Brief: ABVC BioPharma Announces Completion Of Subject Recruitment For Interim Analysis On ADHD Phase IIb Clinical Study
17/10/2023 13:49
Oct 17 (Reuters) - ABVC Biopharma Inc ABVC.O :
* ABVC BIOPHARMA ANNOUNCES COMPLETION OF SUBJECT RECRUITMENT
FOR
INTERIM ANALYSIS ON ADHD PHASE IIB CLINICAL STUDY
Source text for Eikon: ID:nGNXRvRsV
Further company coverage: ABVC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon
Brief: Abvc Biopharma Inc Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: ABVC Biopharma Concluded That Financial Statements For FY Ended Dec 31, 2023 Should No Longer Be Relied Upon Due To Errors In Financial Statements
Brief: ABVC Biopharma Inc On March 5, Leeds Chow Resigns As CFO Of Abvc Biopharma
Brief: ABVC Biopharma Secures $200,000 In First Cash Licensing Payment From Oncology Products Partner